Low Level of TERC Gene Amplification between Chronic Myeloid Leukaemia Patients Resistant and Respond to Imatinib Mesylate Treatment

siRNA-mediated Inhibition of hTERC Enhances Radiosensitivity of Cervical Cancer

(2013) Min Chen et al.   Asian Pacific Journal of Cancer Prevention

Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx

(2012) Yu Liu et al.   Diagnostic Pathology

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

(2011) G. Gugliotta et al.   BLOOD

Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia

(2011) Jorge Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY

Amplification of the Telomerase RNA Component Gene in the Process of Human Esophageal Carcinogenesis

(2011) Qiang Chen et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Fluorescence in situ hybridization analysis of the hTERC region in acute myeloid leukemia patients

(2011) Ozge Ozer et al.   Turkish Journal of Hematology

Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions

(2009) Nadja Kokalj-Vokač et al.   CANCER GENETICS AND CYTOGENETICS

Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells

(2008) Ying Cao et al.   CANCER SCIENCE

Understanding and exploitinghTERTpromoter regulation for diagnosis and treatment of human cancers

(2008) Satoru Kyo et al.   CANCER SCIENCE

Leukemic cells with increased telomerase activity exhibit resistance to imatinib

(2008) Osamu Yamada et al.   LEUKEMIA & LYMPHOMA